No Data
Autonomix Medical | 10-Q: Quarterly report
Autonomix Medical Launches Public Offering; Shares Drop
Autonomix Medical Reports New Topline Results From First 15 Patients' 7-Day Data Highlighting Significant Impact On Treatment Of Pancreatic Cancer Pain With Maintained Pain Reduction; 79% Responder Rate Achieved With Zero Opioid Use And Quality Of...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Express News | Autonomix Medical Inc - 79% Responder Rate Achieved With Zero Opioid Use
Express News | Autonomix Medical, Inc. Reports New Positive Topline Results From First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain With Maintained Pain Reduction
No Data
No Data